Replies to post #684097 on NorthWest Biotherapeutics Inc (NWBO)

[iclight]

There was also failure by the authors to correctly disclose their conflicts of interest.

Please address the multiple Jama "contributors" who had the EXACT SAME CONFLICTS OF INTEREST.

Your nitpicking is irrelevant as they got the majority of their criticism correct. The company could have avoided criticism if they actually released the full dataset but yet they don't even have the data the FDA wants for the ECA, and they refuse to release the original control arm data.

Shill.

[eagle8]

Can't these people be pilloried by this or that person?
Now or later?
It's a shame!


GLTU

[hope4patients]

Absolutely correct.

[meirluc]

Regardless of Dr. Liau's misstatement that 90% of the original
placebos crossed over, all those sloppy authors had to do was
to look at the JAMA article graph that presented the post
progression survival times of all the crossovers and there were
only 64 such patients in the trial.

Even if at the end of the trial, only about 92 of the original
99 placebos were left ( about 7 dropped out?), the 64 crossovers
barely comprised 70% of those 92 original placebos, not 90%.

Instead of revising the article by correcting only one of
several outrageous errors, the entire article should have been
withdrawn.

[Arby2000]

Given an expected binary event - MHRA approval - in the next 30 - 90 days, is there any other mud these slimeballs can sling at DCVAX-L, NWBO, Linda Liau, et al., when positive news breaks?

Fudsters, longs know you all are itching to post all your old arguments - it is grapefruit juice, ATLD-DC is not DCVAX-L, post hoc SAP, PFS failed, NWBO does not have the license from UCLA, etc. So just hold off on that barrage of posts and do not clutter up this board with your repeated and refuted allegations.